Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, Sepsis Diagnostics
Get Sample Copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=391
Sepsis is emerging as one of the leading causes of mortality around the globe. However, early detection can improve the outcomes, hence the demand for sepsis diagnostics is also rising. Major companies in the market are also focusing on introducing technically advanced tools and techniques to provide sepsis diagnosis at an early stage. Companies are also entering into mergers and acquisitions to carry research and development activity and expand globally. New products are also being launched, while some products have already received the U.S. Food and Drugs Administration (FDA) clearance to be used for diagnosis purpose. According to the new research by Fact.MR, the global sepsis diagnostics market is likely to grow at a faster phase between 2017 and 2026. The global market for sepsis diagnostics is also projected to bring in US$ 707.3 million revenue by 2026 end.
Conventional Diagnostics to be the Most-Preferred diagnostic Method
Compared to the automated diagnostics, conventional diagnostics is likely to emerge as the most-preferred sepsis diagnosis method. Towards 2026 end, conventional diagnostics is projected to generate more than US$ 400 million revenue. Conventional methods for diagnosis of sepsis is still the most-preferred one due to the low cost and it also leads to the timely changes to appropriate therapy.
Assays & Reagents to Emerge as the Top-Selling Product
Among various products in sepsis diagnostics market, assays & reagents are likely to emerge as the top-selling products. Assays & reagents are projected to surpass US$ 300 million revenue by end of the forecast period. Reagents and assays kits are showing lucrative growth due to the introduction of technically advanced tests by key players. Moreover, assays and reagents facilitate early diagnosis of sepsis.
Gram-positive Bacterial Sepsis to Hold the Largest Share on Basis of Pathogens Causing Septicemia
Gram-positive bacterial sepsis segment is likely to account for the maximum share in terms of revenue in the global market for sepsis diagnostics. Gram-positive bacterial sepsis are projected to reach close to US$ 300 million revenue by 2026 end. Although bacteria causes sepsis on a large scale, the increase in sepsis is due to the gram-positive sepsis. Various studies carried on sepsis are showing that gram-positive bacteria accounts for maximum septic shock and severe sepsis cases. Moreover, the mortality rate due to gram-positive infection is high as compared to the gram-negative infection. Hence, therapeutic protocols are being undertaken to manage both gram-positive and gram-negative sepsis.
Browse Complete Market Report with TOC Here @ https://www.factmr.com/report/391/sepsis-diagnostics-market
Microbiology Technology to Witness Attractive Growth between 2017 and 2026
Compared to the various technologies, microbiology is likely to show attractive growth between 2017 and 2026. Microbiology technology is projected to reach nearly US$ 300 million revenue by 2026 end. It helps in identifying microorganisms for sepsis diagnosis and quantitative detection through culture media tests. Meanwhile, molecular diagnostics is also gaining traction in the market. Factors contributing to the growth of molecular diagnostics are accurate results and low turnaround time.
The report also profiles companies that are expected to remain active in the expansion of global sepsis diagnostics market through 2026, which include Abionic SA, Biomérieux SA, Siemens Healthineers, Thermo Fisher Scientific Inc., Quidel Corporation, Becton, Dickinson and Company, Luminex Corporation, Abbott Laboratories, Inc., Qiagen NV, T2 Biosystems, Inc., Roche Holdings AG (Roche Diagnostics Limited), and Danaher Corporation (Beckman Coulter, Inc.).
For any query, connect with an Analyst @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=391
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, Sepsis Diagnostics here
News-ID: 1741752 • Views: 197
More Releases from Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
More Releases for Sepsis
Sepsis Diagnosis Market - Latest Trends, Forecast
Stratview Research announces the launch of a new research report on the Sepsis Diagnosis Market: By Technology (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), By Type of Testing (Blood Culture Media, and Instruments), By Mode of Testing (Automated, Semi-Automated), By Site of Testing (Laboratory Based, Patient Bed Side (POC)), By Type of Sepsis (Pathogen) (Bacterial, Fungal), By Testing Facility (Hospitals, Clinics, and Others), By Region (North America, Western Europe, Asia-Pacific,
Sepsis Diagnosis Market - Latest Trends, Capability Assessment up to 2025
Stratview Research announces the launch of a new research report on the Sepsis Diagnosis Market. This extensive report from Stratview Research, studies the clinical diagnostics market - sepsis diagnosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the
Sepsis Therapeutics Market: Regional Analysis by 2021
Sepsis is a serious medical condition that is characterized by an uncontrolled immune response to an infection and is a leading cause of mortality worldwide. This irresistible immune response of a patient is also known as Systemic Inflammatory Response Syndrome (SIRS). In severe cases of sepsis, the infection leads to a significant drop in blood pressure named as septic shock. The septic shock will instantaneously lead to failure of other
Sepsis Therapeutics Market; Key Trends and Opportunities
Sepsis, also known as septicemia, is a life-threatening disease caused when the body responds to an infection. Sepsis leads to a series of reactions that causes widespread inflammation throughout the body and could result in septic shock, a medical emergency. Sepsis is categorized by the presence of numerous bacteria in the blood that are actively dividing. These changes could lead to organ dysfunction such as depression of heart, collapse of
A Study on Sepsis Diagnostics Market
According to the report “Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, the Global Sepsis Diagnostics Market was worth USD 370 million
Develop Business Strategies Of Sepsis Market 2021
"The Report OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Sepsis Market Sepsis patients suffer from a series of diverse complications arising from the presence of pathogens and/or their toxins in the blood or tissues, which cause a rapidly progressing hyperactive host immune response and cellular dysfunction leading to mortality rates near 50%